A randomized phase II study of anlotinib combined with STUPP versus STUPP alone in patients with newly diagnosed glioblastoma (GBM)

被引：0
|
作者：
Chen, Yuan Yuan Yuan
Dong, Baiqiang
Chen, Zhongping
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Neurosurg Neurooncol, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2079
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A FEASIBILITY STUDY OF THE NATIVIS VOYAGER® SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Barkhoudarian, Garni
    Chowdhary, Sajeel
    Blondin, Nicholas
    Kesari, Santosh
    NEURO-ONCOLOGY, 2018, 20 : 16 - 17
  • [32] A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma
    Cao, Toni
    Gu, Yuan
    Yagmurlu, Banu
    Yerraballa, Hari Priya
    Bertrand, Sophie
    Naya, Lewis
    Miller, Kate
    Iv, Michael
    Soltys, Scott G.
    Patel, Chirag B.
    Nagpal, Seema
    Thomas, Reena Parada
    Brown, Martin
    Recht, Lawrence David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study
    Illic, Rosanda
    Somma, Teresa
    Savic, Dragan
    Frio, Federico
    Milicevic, Mihailo
    Solari, Domenico
    Nikitovic, Marina
    Lavrnic, Slobodan
    Raicevic, Savo
    Milosevic, Snezana
    Cavallo, Luigi Maria
    Cappabianca, Paolo
    Grujicic, Danica
    WORLD NEUROSURGERY, 2017, 104 : 581 - 588
  • [34] Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Casucci, Danielle
    Mechtler, Laszlo
    Uhlmann, Erik J.
    Ciesielski, Michael J.
    Fenstermaker, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Grossman, S. A.
    Ye, X.
    Chamberlain, M. C.
    Mikkelsen, T.
    Batchelor, T. T.
    Desideri, S.
    Piantadosi, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] RTOG 0525: Molecular correlates from randomized phase III trial of newly diagnosed glioblastoma (GBM).
    Aldape, K. D.
    Wang, M.
    Sulman, E. P.
    Cahill, D. P.
    Hegi, M.
    Colman, H.
    Jones, G.
    Chakravarti, A.
    Mehta, M. P.
    Andrews, D. W.
    Long, L.
    Diefes, K.
    Heathcock, L.
    Jenkins, R.
    Schultz, C. J.
    Gilbert, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM).
    Omuro, A. M. P.
    Beal, K.
    Karimi, S.
    Correa, D.
    Chan, T. A.
    DeAngelis, L. M.
    Gavrilovic, I. T.
    Nolan, C.
    Hormigo, A.
    Lassman, A. B.
    Kaley, T. J.
    Mellinghoff, I. K.
    Grommes, C.
    Panageas, K.
    Reiner, A. S.
    Barradas, R.
    Abrey, L. E.
    Gutin, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] PHASE II STUDY OF FIXED-DOSE RATE (FDR) GEMCITABINE AS A RADIOSENSITIZER FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Fabi, A.
    Mirri, A. M.
    Metro, G.
    Felici, A.
    Vidiri, A.
    Pace, A.
    Carosi, M. A.
    Cognetti, F.
    Occhipinti, E. M.
    Carapella, C. M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1123 - 1123
  • [39] Phase II Study of Bevacizumab (BEV), Temozolomide (TMZ) and Hypofractionated Stereotactic Radiotherapy (HFSRT) for Newly Diagnosed Glioblastoma (GBM)
    Beal, K.
    Omuro, A.
    Karimi, S.
    Correa, D.
    Chan, T. A.
    DeAngelis, L. M.
    Yamada, Y.
    Abrey, L. E.
    Gutin, P. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S129 - S129
  • [40] Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
    Roth, Patrick
    Gorlia, Thierry
    Reijneveld, Jaap C.
    de Vos, Filip
    Idbaih, Ahmed
    Frenel, Jean-Sebastien
    Le Rhun, Emilie
    Sepulveda, Juan Manuel
    Perry, James
    Masucci, G. Laura
    Freres, Pierre
    Hirte, Hal
    Seidel, Clemens
    Walenkamp, Annemiek
    Lukacova, Slavka
    Meijnders, Paul
    Blais, Andre
    Ducray, Francois
    Verschaeve, Vincent
    Nicholas, Garth
    Balana, Carmen
    Bota, Daniela A.
    Preusser, Matthias
    Nuyens, Sarah
    Dhermain, Frederic
    van den Bent, Martin
    O'Callaghan, Chris J.
    Vanlancker, Maureen
    Mason, Warren
    Weller, Michael
    NEURO-ONCOLOGY, 2024, 26 (09) : 1670 - 1682
12345